<strong>Board</strong> <strong>of</strong> <strong>Directors</strong> <strong>Meeting</strong>, <strong>29</strong> <strong>March</strong> <strong>2012</strong>Agenda Item 10Scoring Thresholds 5 4 3 2 1 Value RatingUnderlying Performance 11% 9% 5% 1%
<strong>Board</strong> <strong>of</strong> <strong>Directors</strong> <strong>Meeting</strong>, <strong>29</strong> <strong>March</strong> <strong>2012</strong>Agenda Item 10Table 1DEVON PARTNERSHIP NHS TRUSTINCOME & EXPENDITURE POSITION AS AT <strong>29</strong>th February <strong>2012</strong> (Month 11)CY BUDGET ACTUAL VARIANCE ForecastBUDGET Month 11 Month 11 Month 11 Outturn£'000 £'000 £'000 £'000 £'0001.0 INCOME1.1 Block 84,861 76,4<strong>29</strong> 76,4<strong>29</strong> 0 84,8281.2 Cost and Volume 34,010 31,167 34,984 3,817 37,5141.3 Clinical <strong>Partnership</strong>s 10,882 9,915 10,590 675 11,5641.4 Other Operating 3,146 2,881 3,056 175 3,3001.5 TOTAL 132,899 120,392 125,059 4,667 137,2062.0 EXPENDITURE2.1 Pay 83,437 76,621 76,313 307 83,7602.2 Non Pay 43,857 38,645 43,971 (5,326) 48,2622.3 TOTAL 127,<strong>29</strong>4 115,266 120,284 (5,019) 132,0223.0 EBITDA 5,606 5,126 4,775 (352) 5,184EBITDA % 4.2% 4.3% 3.8% 3.8%4.0 4.1 Other Costs 2,806 2,551 2,509 43 2,7494.2 PDC Dividend 2,015 1,847 1,513 335 1,6504.5 TOTAL 4,821 4,398 4,022 377 4,3995.0PRE IMPAIRMENT NETSURPLUS / (DEFICIT) 785 728 753 25 7856.0 Impairment 0 0 25 (25) 5007.0POST IMPAIRMENT SURPLUS /(DEFICIT) 785 728 728 (0) 285Page 87 <strong>of</strong> 156
- Page 1 and 2:
Devon Partnership NHS Trust Board o
- Page 3 and 4:
3DEVON PARTNERSHIP NHS TRUSTBOARD O
- Page 5 and 6:
4DEVON PARTNERSHIP NHS TRUSTBOARD O
- Page 8 and 9:
Board of Directors Meeting, 29 Marc
- Page 10 and 11:
Board of Directors Meeting, 29 Marc
- Page 12 and 13:
Board of Directors Meeting, 29 Marc
- Page 14 and 15:
Board of Directors Meeting, 29 Marc
- Page 16 and 17:
Board of Directors Meeting, 29 Marc
- Page 18 and 19:
Page 18 of 156
- Page 20 and 21:
Board of Directors Meeting, 29 Marc
- Page 22 and 23:
Board of Directors Meeting, 29 Marc
- Page 24 and 25:
Page 24 of 156
- Page 26 and 27:
Links to Strategic Aims:Safe x Reco
- Page 28 and 29:
2.2.2 The key points for the Board
- Page 30 and 31:
Impact across many of these issues
- Page 32 and 33:
Board of Directors Meeting, 29 Marc
- Page 34 and 35:
Board of Directors Meeting, 29 Marc
- Page 36 and 37: Action required, including Recommen
- Page 38 and 39: 4 Quality improvementBoard of Direc
- Page 40 and 41: 6. Compliance with Trust standards
- Page 42 and 43: 7. The experience of using services
- Page 44 and 45: Board of Directors Meeting, 29 Marc
- Page 46 and 47: 7.5.4 Acting on feedbackBoard of Di
- Page 48 and 49: 9.2.4 Outbreaks and Incidents• Th
- Page 50 and 51: Experience 2Appendix 1: Quality, sa
- Page 52 and 53: CQUIN 4Effectiveness 3Board of Dire
- Page 54 and 55: Appendix 32012/13 CQUIN targetsBoar
- Page 56 and 57: Links to Strategic Aims:Safe x Reco
- Page 58 and 59: Board of Directors Meeting, 29 Marc
- Page 60 and 61: Board of Directors Meeting, 29 Marc
- Page 62 and 63: Board of Directors Meeting, 29 Marc
- Page 64 and 65: PersonalisedXThis report references
- Page 66 and 67: Board of Directors Meeting, 29 Marc
- Page 68 and 69: the Trust Board and all staffBoard
- Page 70 and 71: Board of Directors Meeting, 29 Marc
- Page 72 and 73: Page 72 of 156Board of Directors Me
- Page 74 and 75: Appendix 4Board of Directors Meetin
- Page 76 and 77: Board of Directors Meeting, 29 Marc
- Page 78 and 79: Board of Directors Meeting, 29 Marc
- Page 80 and 81: Board of Directors Meeting, 29 Marc
- Page 82 and 83: Page 82 of 156Board of Directors Me
- Page 84 and 85: Page 84 of 156
- Page 89 and 90: Board of Directors Meeting, 29 Marc
- Page 92: Links to Strategic Aims:Safe X Reco
- Page 95 and 96: Board of Directors Meeting, 29 Marc
- Page 97 and 98: 12DEVON PARTNERSHIP NHS TRUSTBOARD
- Page 99 and 100: Board of Directors Performance Repo
- Page 101 and 102: Board of Directors Performance Repo
- Page 103 and 104: 6,3936,5076,5396,1116,8496,9156,393
- Page 105 and 106: Board of Directors Performance Repo
- Page 107 and 108: ASSURANCE FRAMEWORK AND CORPORATE R
- Page 109 and 110: 13DEVON PARTNERSHIP NHS TRUSTBOARD
- Page 111 and 112: Board of Directors Meeting, 29 Marc
- Page 113 and 114: Board of Directors Meeting, 29 Marc
- Page 115 and 116: Board of Directors Meeting, 29 Marc
- Page 117 and 118: Board of Directors Meeting, 29 Marc
- Page 119 and 120: Board of Directors Meeting, 29 Marc
- Page 121 and 122: Board of Directors Meeting, 29 Marc
- Page 123 and 124: Assurance Framework andCorporate Ri
- Page 125 and 126: Board of Directors Meeting, 29 Marc
- Page 127 and 128: Board of Directors Meeting, 29 Marc
- Page 129 and 130: Board of Directors Meeting, 29 Marc
- Page 131 and 132: Guidance - 5 Steps to Risk Assessme
- Page 133 and 134: Board of Directors Meeting, 29 Marc
- Page 135 and 136: Board of Directors Meeting, 29 Marc
- Page 137 and 138:
KeyStandingcommitteeNED chairedStan
- Page 139 and 140:
Appendix D - Risk Escalation Matrix
- Page 141 and 142:
14DEVON PARTNERSHIP NHS TRUSTBOARD
- Page 143 and 144:
Board of Directors Meeting, 29 Marc
- Page 145 and 146:
Board of Directors Meeting, 29 Marc
- Page 147 and 148:
15DEVON PARTNERSHIP NHS TRUSTBOARD
- Page 149 and 150:
Board of Directors Meeting, 29 Marc
- Page 151 and 152:
Board of Directors Meeting, 29 Marc
- Page 153 and 154:
Board of Directors Meeting, 29 Marc
- Page 155 and 156:
Board of Directors Meeting, 29 Marc